Global Health Press

Tag - vaccine

Literature update ViVa week 18-2026

1. MenB vaccines show lab cross-protection against MenX—but conjugates are still the gold standard In this laboratory study, investigators evaluated whether the protein-based meningococcal B vaccines 4CMenB (Bexsero)...

Why this history matters now

The story of early TBE research in the Soviet Union is more than a historical curiosity. It offers a vivid case study of how science, politics, and social conditions intertwine. It reminds us that medical breakthroughs...

Vaccines and Vaccination (ViVa) news

Over roughly the past week, formal NITAG/agency outputs have largely reinforced and operationalized earlier 2026 policy decisions, while the most clearly “new” developments sit in World/Regional Immunization Week...

Global vaccine production

Global vaccine output remains highly concentrated among a few major producers. Here’s a snapshot of the latest estimates: (Note: Many companies do not publish per‑vaccine production figures; numbers marked with “~” are...

Selected vaccine myths versus evidence

Download Infographic Overview Whole-cell Pertussis & Brain Damage: No causal link exists; earlier associations were actually coincidental onsets of inherited conditions like Dravet syndrome. Measles/MMR &...

Adverse Events vs. Side Effects

Download Infographic Overview An adverse event (AE) is any medical event occurring after vaccination, regardless of whether it is causally related. A side effect is a medical event that is confirmed to be caused by a...

Vaccine news January 2026

Europe kicked off 2026 by adding more brains to the vaccine bureaucracy, designating a new WHO Collaborating Centre to help NITAGs turn messy evidence into cleaner policy decisions. In theory, this means fewer hand‑wavy...